BACKGROUND: Physical activity is considered an important and determining factor for the cancer patient's physical well-being and quality of life. However, cancer treatment may disrupt the practice of physical activity, and the prevention of sedentary lifestyles in cancer survivors is imperative. PURPOSE: The current study aimed at investigating self-reported physical activity behaviour, exercise motivation and information in cancer patients undergoing chemotherapy. METHODS AND SAMPLE: Using a cross-sectional design, 451 patients (18-65 years) completed a questionnaire assessing pre-illness and present physical activity; motivation and information received. RESULTS: Patients reported a significant decline in physical activity from pre-illness to the time in active treatment (p<0.001). Amongst the respondents, 68% answered that they believed exercise to be beneficial; and 78% claimed not exercising as much as desired. Exercise barriers included fatigue (74%) and physical discomfort (45%). Present physical activity behaviour was associated with pre-illness physical activity behaviour (p<0.001), exercise belief (p<0.001), and diagnosis (p<0.001). More patients <40 years than patients >40 years (OR 0.36, p<0.001); more men than women (OR 2.12, p<0.001); and more oncological than haematological patients (OR 0.41, p<0.001) stated being informed about physical activity. Moreover patients who claimed to have been informed about exercise were more in agreement with being able to exercise while undergoing chemotherapy (OR 1.69, p=0.023). CONCLUSIONS: This study suggests that Danish adult cancer patients in chemotherapy experience a significant decline in physical activity behaviour. Results indicate a general positive interest in physical activity amongst the patients, which however may be only suboptimally exploited.
BACKGROUND: Physical activity is considered an important and determining factor for the cancerpatient's physical well-being and quality of life. However, cancer treatment may disrupt the practice of physical activity, and the prevention of sedentary lifestyles in cancer survivors is imperative. PURPOSE: The current study aimed at investigating self-reported physical activity behaviour, exercise motivation and information in cancerpatients undergoing chemotherapy. METHODS AND SAMPLE: Using a cross-sectional design, 451 patients (18-65 years) completed a questionnaire assessing pre-illness and present physical activity; motivation and information received. RESULTS:Patients reported a significant decline in physical activity from pre-illness to the time in active treatment (p<0.001). Amongst the respondents, 68% answered that they believed exercise to be beneficial; and 78% claimed not exercising as much as desired. Exercise barriers included fatigue (74%) and physical discomfort (45%). Present physical activity behaviour was associated with pre-illness physical activity behaviour (p<0.001), exercise belief (p<0.001), and diagnosis (p<0.001). More patients <40 years than patients >40 years (OR 0.36, p<0.001); more men than women (OR 2.12, p<0.001); and more oncological than haematological patients (OR 0.41, p<0.001) stated being informed about physical activity. Moreover patients who claimed to have been informed about exercise were more in agreement with being able to exercise while undergoing chemotherapy (OR 1.69, p=0.023). CONCLUSIONS: This study suggests that Danish adult cancerpatients in chemotherapy experience a significant decline in physical activity behaviour. Results indicate a general positive interest in physical activity amongst the patients, which however may be only suboptimally exploited.
Authors: Elizabeth A Salerno; Eva Culakova; Amber S Kleckner; Charles E Heckler; Po-Ju Lin; Charles E Matthews; Alison Conlin; Lora Weiselberg; Jerry Mitchell; Karen M Mustian; Michelle C Janelsins Journal: J Clin Oncol Date: 2021-08-18 Impact factor: 50.717
Authors: C F van Uden-Kraan; M J M Chinapaw; C H C Drossaert; I M Verdonck-de Leeuw; L M Buffart Journal: Support Care Cancer Date: 2013-02-12 Impact factor: 3.603
Authors: Karianne Vassbakk-Brovold; Sveinung Berntsen; Liv Fegran; Henrik Lian; Odd Mjåland; Svein Mjåland; Stephen Seiler; Christian Kersten Journal: PLoS One Date: 2015-07-15 Impact factor: 3.240
Authors: Laurien M Buffart; Jannique G Z van Uffelen; Ingrid I Riphagen; Johannes Brug; Willem van Mechelen; Wendy J Brown; Mai J M Chinapaw Journal: BMC Cancer Date: 2012-11-27 Impact factor: 4.430
Authors: Tom Møller; Christian Lillelund; Christina Andersen; Bent Ejlertsen; Lone Nørgaard; Karl Bang Christensen; Eva Vadstrup; Finn Diderichsen; Carsten Hendriksen; Kira Bloomquist; Lis Adamsen Journal: BMJ Open Date: 2013-11-04 Impact factor: 2.692